ATE449166T1 - Chimere zielmoleküle mit regulierbarer aktivität - Google Patents

Chimere zielmoleküle mit regulierbarer aktivität

Info

Publication number
ATE449166T1
ATE449166T1 AT97952131T AT97952131T ATE449166T1 AT E449166 T1 ATE449166 T1 AT E449166T1 AT 97952131 T AT97952131 T AT 97952131T AT 97952131 T AT97952131 T AT 97952131T AT E449166 T1 ATE449166 T1 AT E449166T1
Authority
AT
Austria
Prior art keywords
molecule
binding molecule
chimeric
activity
binding
Prior art date
Application number
AT97952131T
Other languages
English (en)
Inventor
Daniel Legendre
Patrice Soumillion
Jacques Fastrez
Original Assignee
Univ Catholique Louvain
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=25047774&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE449166(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Univ Catholique Louvain filed Critical Univ Catholique Louvain
Application granted granted Critical
Publication of ATE449166T1 publication Critical patent/ATE449166T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/536—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase
    • G01N33/542—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase with steric inhibition or signal modification, e.g. fluorescent quenching
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/62—DNA sequences coding for fusion proteins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/78—Hydrolases (3) acting on carbon to nitrogen bonds other than peptide bonds (3.5)
    • C12N9/86—Hydrolases (3) acting on carbon to nitrogen bonds other than peptide bonds (3.5) acting on amide bonds in cyclic amides, e.g. penicillinase (3.5.2)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y305/00—Hydrolases acting on carbon-nitrogen bonds, other than peptide bonds (3.5)
    • C12Y305/02—Hydrolases acting on carbon-nitrogen bonds, other than peptide bonds (3.5) in cyclic amides (3.5.2)
    • C12Y305/02006—Beta-lactamase (3.5.2.6)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
    • C07K2319/735—Fusion polypeptide containing domain for protein-protein interaction containing a domain for self-assembly, e.g. a viral coat protein (includes phage display)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Hematology (AREA)
  • Physics & Mathematics (AREA)
  • Urology & Nephrology (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Food Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Cell Biology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Bakery Products And Manufacturing Methods Therefor (AREA)
AT97952131T 1996-11-27 1997-11-26 Chimere zielmoleküle mit regulierbarer aktivität ATE449166T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/757,425 US6500660B1 (en) 1996-11-27 1996-11-27 Chimeric target molecules having a regulatable activity
PCT/IB1997/001643 WO1998023731A2 (en) 1996-11-27 1997-11-26 Chimeric target molecules having a regulatable activity

Publications (1)

Publication Number Publication Date
ATE449166T1 true ATE449166T1 (de) 2009-12-15

Family

ID=25047774

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97952131T ATE449166T1 (de) 1996-11-27 1997-11-26 Chimere zielmoleküle mit regulierbarer aktivität

Country Status (10)

Country Link
US (1) US6500660B1 (de)
EP (1) EP0958351B1 (de)
JP (1) JP4416185B2 (de)
AT (1) ATE449166T1 (de)
AU (1) AU5571998A (de)
DE (1) DE69739664D1 (de)
DK (1) DK0958351T3 (de)
ES (1) ES2336634T3 (de)
PT (1) PT958351E (de)
WO (1) WO1998023731A2 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1349869A4 (de) * 2000-11-08 2007-12-12 Commw Scient Ind Res Org Verfahren zur identifizierung antibakterieller verbindungen
WO2003004989A2 (en) 2001-06-21 2003-01-16 Millennium Pharmaceuticals, Inc. Compositions, kits, and methods for identification, assessment, prevention, and therapy of breast cancer
KR100428998B1 (ko) * 2001-09-10 2004-04-28 한국과학기술원 모체 단백질과는 크기와 서열이 다른 단백질의 변이집단을생산하는 방법
GB0209878D0 (en) * 2002-04-30 2002-06-05 Glaxosmithkline Biolog Sa Vaccine
TR201820051T4 (tr) * 2008-06-19 2019-01-21 Prothix Bv Anti-faktör XI Antikorlarının Trombüs Oluşumunun Engellenmesi Veya Tedavisi İçin Kullanılması
DE102022000897A1 (de) 2022-03-15 2023-09-21 Ruhr-Universität Bochum, Körperschaft des öffentlichen Rechts Implantierbarer Biosensor

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1988002757A1 (en) * 1986-10-17 1988-04-21 Saramane Pty. Ltd.; Hybrid proteins or polypeptides
EP0397834B1 (de) * 1988-10-28 2000-02-02 Genentech, Inc. Verfahren zum nachweis von aktiven domänen und aminosäureresten in polypeptiden und hormonvarianten
EP0555357B1 (de) * 1990-10-22 2002-07-03 Genentech, Inc. Verfahren zur modifizierung von dna und zur detektion der wirkungen auf die interaktion von modifizierten polypeptiden und zielsubstraten
AU4238893A (en) * 1992-05-07 1993-11-29 Regents Of The University Of California, The Novel diphtheria toxin-based molecules
US5674681A (en) * 1994-12-06 1997-10-07 Rothenberg; Barry E. Methods to identify hemochromatosis

Also Published As

Publication number Publication date
EP0958351B1 (de) 2009-11-18
WO1998023731A2 (en) 1998-06-04
ES2336634T3 (es) 2010-04-14
JP4416185B2 (ja) 2010-02-17
US6500660B1 (en) 2002-12-31
AU5571998A (en) 1998-06-22
WO1998023731A3 (en) 1998-11-12
PT958351E (pt) 2010-02-17
JP2001515346A (ja) 2001-09-18
DK0958351T3 (da) 2010-03-15
DE69739664D1 (de) 2009-12-31
EP0958351A2 (de) 1999-11-24

Similar Documents

Publication Publication Date Title
DE69638269D1 (de) Hochaffine humane antikörper gegen tumorantigene
DE69835143D1 (de) Selektion von proteinen mittels rns-protein fusionen
ATE165397T1 (de) Screeningtest für den nachweis von dna-bindenden molekülen
DE69714654D1 (de) Verwendung von einem Metalloporphyrinkonjugat für den Nachweis biologischer Verbindungen
MX9304363A (es) Metodo para enlace intracelular de moleculas blanco.
ATE267394T1 (de) Nachweis der krankheitsbedingten konformation eines proteins
WO1998035693A3 (en) Detection and modulation of the iaps and naip for the diagnosis and treatment of proliferative disease
ATE246361T1 (de) Verfahren zur bestimmung von ige
ATE522610T1 (de) Menschliche, metabotrope glutamatrezeptor- subtypen (hmr6) und verwandte dns-verbindungen
ATE555202T1 (de) Verfahren zur lieferung von rna-interferenz und verwendungen damit
DE69232309D1 (de) Weitgehend reine rezeptorartige, tgf-beta-1-bindende moleküle und deren verwendungen
DE69531309D1 (de) Entwurf diskontinuierlicher sonden unter verwendung von hybritopemapping
DK0770876T3 (da) En screening-fremgangsmåde til at identificere ligander for målproteiner
DE59107797D1 (de) Verfahren zum Nachweis von phosphoryliertes Tyrosin enthaltenden Proteinen
ATE383172T1 (de) Oligonukleotide welche spezifisch retrovirale nukleokapsid-proteine binden
ATE449166T1 (de) Chimere zielmoleküle mit regulierbarer aktivität
BRPI0416270A (pt) método para detectar um analito em uma amostra, e, método e kit para detectar um anticorpo especìfico de uma amostra
ATE274188T1 (de) Verfahren zur bestimmung eines analyten und kit dafür
WO2004069860A3 (en) Isg15-conjugated proteins
EA199800843A1 (ru) Компьютерный способ создания химических структур, имеющих общие функциональные характеристики
DE69825583D1 (de) Methode zum bestimmen der aktivierung von zytokinrezeptoren mit hilfe eines antikörpers
CA2375798A1 (en) Capillary electrophoresis method for screening for affinity ligands using a detectable competitive ligand
DE50203136D1 (de) Verfahren zum Nachweis von Analyten in Proben mittels Analysenelementen
ATE171545T1 (de) Verfahren zur bestimmung des lysingehaltes von samen
ATE466953T1 (de) Verfahren zur identifizierung aktivierter polymer-komplexe zur sekundären stellen-spezifischen modifikation von protein ziel-gruppen.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0958351

Country of ref document: EP